Skip to main content
Premium Trial:

Request an Annual Quote

ParAllele Bioscience Recently Won $660K from Two NIH Grants

NEW YORK, Dec. 29 (GenomeWeb News) - ParAllele Bioscience has won around $660,000 through a pair of recent grants from the US National Institutes of Health, according to the NIH.

 

The grants, which the NIH said are effective as of Dec. 26, but that ParAllele had not previously disclosed, include:

  • $443,897 to develop a high-throughput genotyping technology; and
  • $214,190 to study variation scanning with mismatch repair detection.

 

A ParAllele spokesperson told GenomeWebNews today that the first of these grants is to develop "ultra-high-throughput" genotyping technology, though the NIH describes it as "high-throughoput."

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.